RANDOMIZED PHASE III TRIAL OF OBSERVATION VERSUS 6 COURSES OF SINGLE-AGENT PACLITAXEL IN PATIENTS (PTS) WITH ADVANCED OVARIAN CANCER WHO ATTAINED A COMPLETE RESPONSE (CR) TO PLATINUM–PACLITAXEL-BASED CHEMOTHERAPY (AFTER-6 PROTOCOL 1)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles